The Anti-Obesity Prescription Drugs Market is expected to register a CAGR of 26% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Anti-Obesity Prescription Drugs Market is categorized by mechanism of action into the following subsegments: Peripherally Acting Drugs, Centrally Acting Drugs. It further presents an analysis based on drug class, i.e., Bupropion and Naltrexone, Orlistat, Lorcaserin, Phentermine and Topiramate, Liraglutide, and distribution channel, i.e., Hospital Pharmacy, Retail Pharmacy, Online Pharmacy. Forecasts up to 2031 are provided. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the Report
The report Anti-Obesity Prescription Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Anti-Obesity Prescription Drugs Market Segmentation
Mechanism of Action
- Peripherally Acting Drugs
- Centrally Acting Drugs
Drug Class
- Bupropion and Naltrexone
- Orlistat
- Lorcaserin
- Phentermine and Topiramate
- Liraglutide
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Anti-Obesity Prescription Drugs Market: Strategic Insights
- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Anti-Obesity Prescription Drugs Market Growth Drivers
- Excessive Rate of Obesity in the World: Rising prevalence of obesity worldwide created a craze for over-the-counter drugs to treat obesity and related disorders.
- FDA New prescription drug approvals: Regulation authorities like FDA approval of new prescription drugs are driving growth in the market as it offers patients with new options for treatment.
- Increased Recognition of Health Concerns: Increased recognition of health concerns that obesity has engulfed – from diabetes to heart disease to joint ailments – will only serve as an incentive for anti-obesity treatment.
Anti-Obesity Prescription Drugs Market Future Trends
- Trend Toward Personalized Medicine: Personalized medicine has to start with genetics and pharmacogenomics which pave the way towards individually tailored anti-obesity medications based on a patient’s genetic background.
- Combination Therapies: Combination therapies are in the research phase of drug companies to improve anti-obesity medications by targeting multiple factors that lead to weight gain.
- Non-Surgical Weight Loss Options: Increasing numbers of people are opting for non-surgical weight loss solutions, with a growing preference for drugs over procedures like bariatric surgery.
Anti-Obesity Prescription Drugs Market Opportunities
- Development of Safer, More Effective Drugs: One important area for innovation is about the development of safer, more effective prescription drugs for the treatment of obesity with fewer side effects.
- Access to New Markets: Growing markets characterized by growing levels of obesity provide pharmaceutical companies with an opportunity to gain access to the regions with anti-obesity drugs.
- Accessible through Over the Counter: With one such prospect is where some prescription drugs would be repackaged for over the counter sale and therefore could reach more people
Anti-Obesity Prescription Drugs Market Regional Insights
The regional trends and factors influencing the Anti-Obesity Prescription Drugs Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Anti-Obesity Prescription Drugs Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for Anti-Obesity Prescription Drugs Market
Anti-Obesity Prescription Drugs Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | 26% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Mechanism of Action
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Anti-Obesity Prescription Drugs Market Players Density: Understanding Its Impact on Business Dynamics
The Anti-Obesity Prescription Drugs Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Anti-Obesity Prescription Drugs Market are:
- BRISTOL-MYERS SQUIBB CO.
- TAKEDA PHARMACEUTICAL
- EISAI COMPANY
- GLAXOSMITHKLINE PLC
- PFIZER INC
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Anti-Obesity Prescription Drugs Market top key players overview
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Anti-Obesity Prescription Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Anti-Obesity Prescription Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Rare Neurological Disease Treatment Market
- Personality Assessment Solution Market
- Sports Technology Market
- Vessel Monitoring System Market
- Vertical Farming Crops Market
- Adaptive Traffic Control System Market
- Automotive Fabric Market
- Truck Refrigeration Market
- Hydrogen Storage Alloys Market
- Helicopters Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 26% during 2021–2031.
The driving factors of the market are the global growth in obesity prevalence rates, developments in the formulation of effective drugs, and rising awareness about obesity-related diseases such as diabetes and heart problems.
Key trends in the market include combination drugs, personalized weight loss medicines, and the increasing use of non-invasive treatments such as oral and injectable drugs.
Key companies in this market are - Novo Nordisk (Saxenda), Eli Lilly (Wegovy), and Johnson & Johnson.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. BRISTOL-MYERS SQUIBB CO.
2. TAKEDA PHARMACEUTICAL
3. EISAI COMPANY
4. GLAXOSMITHKLINE PLC
5. PFIZER INC
6. SHIONOGI USA INC
7. VIVUS INC
8. ZAFGEN INC
9. NORGINE BV
10. BOEHRINGER INGELHEIM GMBH.
11. 7TM PHARMA
12. ZYDUS CADILA
13. AKRIMAX PHARMACEUTICALS
14. ZEALAND PHARMA
15. ARROWHEAD RESEARCH
Get Free Sample For